'en:naldecon'
(id=7235938 ; fe=en:naldecon ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=311 creation date=2017-06-26 touchdate=2025-05-03 16:17:04.000) ≈ 13 relations sortantes
- en:naldecon --
r_associated #0: 36 / 1 ->
en:chlorpheniramine 0.1 mg/ml / phenylephrine 0.25 mg/ml / phenylpropanolamine 1 mg/ml / phenyltoloxamine 0.4 mg/ml oral solution
n1=en:naldecon | n2=en:chlorpheniramine 0.1 mg/ml / phenylephrine 0.25 mg/ml / phenylpropanolamine 1 mg/ml / phenyltoloxamine 0.4 mg/ml oral solution | rel=r_associated | relid=0 | w=36
- en:naldecon --
r_associated #0: 35 / 0.972 ->
en:naldecon pediatric
n1=en:naldecon | n2=en:naldecon pediatric | rel=r_associated | relid=0 | w=35
- en:naldecon --
r_associated #0: 31 / 0.861 ->
en:benzhydryl compounds
n1=en:naldecon | n2=en:benzhydryl compounds | rel=r_associated | relid=0 | w=31
- en:naldecon --
r_associated #0: 31 / 0.861 ->
en:phenylephrine
n1=en:naldecon | n2=en:phenylephrine | rel=r_associated | relid=0 | w=31
- en:naldecon --
r_associated #0: 30 / 0.833 ->
en:chlorpheniramine 0.5 mg/ml / phenylephrine 1.25 mg/ml / phenylpropanolamine 5 mg/ml / phenyltoloxamine 2 mg/ml oral solution
n1=en:naldecon | n2=en:chlorpheniramine 0.5 mg/ml / phenylephrine 1.25 mg/ml / phenylpropanolamine 5 mg/ml / phenyltoloxamine 2 mg/ml oral solution | rel=r_associated | relid=0 | w=30
- en:naldecon --
r_associated #0: 30 / 0.833 ->
en:chlorpheniramine 5 mg / phenylephrine 10 mg / phenylpropanolamine 40 mg / phenyltoloxamine 15 mg extended release oral capsule
n1=en:naldecon | n2=en:chlorpheniramine 5 mg / phenylephrine 10 mg / phenylpropanolamine 40 mg / phenyltoloxamine 15 mg extended release oral capsule | rel=r_associated | relid=0 | w=30
- en:naldecon --
r_associated #0: 29 / 0.806 ->
en:drug combinations
n1=en:naldecon | n2=en:drug combinations | rel=r_associated | relid=0 | w=29
- en:naldecon --
r_associated #0: 29 / 0.806 ->
en:phenylpropanolamine hydrochloride
n1=en:naldecon | n2=en:phenylpropanolamine hydrochloride | rel=r_associated | relid=0 | w=29
- en:naldecon --
r_associated #0: 28 / 0.778 ->
en:chlorpheniramine
n1=en:naldecon | n2=en:chlorpheniramine | rel=r_associated | relid=0 | w=28
- en:naldecon --
r_associated #0: 26 / 0.722 ->
en:chlorpheniramine 5 mg / phenylephrine 10 mg / phenylpropanolamine 40 mg / phenyltoloxamine 15 mg extended release oral tablet
n1=en:naldecon | n2=en:chlorpheniramine 5 mg / phenylephrine 10 mg / phenylpropanolamine 40 mg / phenyltoloxamine 15 mg extended release oral tablet | rel=r_associated | relid=0 | w=26
- en:naldecon --
r_associated #0: 26 / 0.722 ->
en:chlorpheniramine, phenylephrine, phenylpropanolamine, phenyltoloxamine drug combination
n1=en:naldecon | n2=en:chlorpheniramine, phenylephrine, phenylpropanolamine, phenyltoloxamine drug combination | rel=r_associated | relid=0 | w=26
- en:naldecon --
r_associated #0: 26 / 0.722 ->
en:phenyltoloxamine
n1=en:naldecon | n2=en:phenyltoloxamine | rel=r_associated | relid=0 | w=26
- en:naldecon --
r_associated #0: 2 / 0.056 ->
en:organic chemical
n1=en:naldecon | n2=en:organic chemical | rel=r_associated | relid=0 | w=2
| ≈ 14 relations entrantes
- en:chlorpheniramine, phenylephrine, phenylpropanolamine, phenyltoloxamine drug combination ---
r_associated #0: 34 -->
en:naldecon
n1=en:chlorpheniramine, phenylephrine, phenylpropanolamine, phenyltoloxamine drug combination | n2=en:naldecon | rel=r_associated | relid=0 | w=34
- en:chlorpheniramine 0.5 mg/ml / phenylephrine 1.25 mg/ml / phenylpropanolamine 5 mg/ml / phenyltoloxamine 2 mg/ml oral solution ---
r_associated #0: 32 -->
en:naldecon
n1=en:chlorpheniramine 0.5 mg/ml / phenylephrine 1.25 mg/ml / phenylpropanolamine 5 mg/ml / phenyltoloxamine 2 mg/ml oral solution | n2=en:naldecon | rel=r_associated | relid=0 | w=32
- en:phenylpropanolamine hydrochloride ---
r_associated #0: 32 -->
en:naldecon
n1=en:phenylpropanolamine hydrochloride | n2=en:naldecon | rel=r_associated | relid=0 | w=32
- en:phenyltoloxamine ---
r_associated #0: 31 -->
en:naldecon
n1=en:phenyltoloxamine | n2=en:naldecon | rel=r_associated | relid=0 | w=31
- en:benzhydryl compounds ---
r_associated #0: 20 -->
en:naldecon
n1=en:benzhydryl compounds | n2=en:naldecon | rel=r_associated | relid=0 | w=20
- en:chlorpheniramine ---
r_associated #0: 20 -->
en:naldecon
n1=en:chlorpheniramine | n2=en:naldecon | rel=r_associated | relid=0 | w=20
- en:chlorpheniramine 0.1 mg/ml / phenylephrine 0.25 mg/ml / phenylpropanolamine 1 mg/ml / phenyltoloxamine 0.4 mg/ml oral solution ---
r_associated #0: 20 -->
en:naldecon
n1=en:chlorpheniramine 0.1 mg/ml / phenylephrine 0.25 mg/ml / phenylpropanolamine 1 mg/ml / phenyltoloxamine 0.4 mg/ml oral solution | n2=en:naldecon | rel=r_associated | relid=0 | w=20
- en:chlorpheniramine 5 mg / phenylephrine 10 mg / phenylpropanolamine 40 mg / phenyltoloxamine 15 mg extended release oral capsule ---
r_associated #0: 20 -->
en:naldecon
n1=en:chlorpheniramine 5 mg / phenylephrine 10 mg / phenylpropanolamine 40 mg / phenyltoloxamine 15 mg extended release oral capsule | n2=en:naldecon | rel=r_associated | relid=0 | w=20
- en:chlorpheniramine 5 mg / phenylephrine 10 mg / phenylpropanolamine 40 mg / phenyltoloxamine 15 mg extended release oral tablet ---
r_associated #0: 20 -->
en:naldecon
n1=en:chlorpheniramine 5 mg / phenylephrine 10 mg / phenylpropanolamine 40 mg / phenyltoloxamine 15 mg extended release oral tablet | n2=en:naldecon | rel=r_associated | relid=0 | w=20
- en:drug combinations ---
r_associated #0: 20 -->
en:naldecon
n1=en:drug combinations | n2=en:naldecon | rel=r_associated | relid=0 | w=20
- en:naldecon pediatric ---
r_associated #0: 20 -->
en:naldecon
n1=en:naldecon pediatric | n2=en:naldecon | rel=r_associated | relid=0 | w=20
- en:phenylephrine ---
r_associated #0: 20 -->
en:naldecon
n1=en:phenylephrine | n2=en:naldecon | rel=r_associated | relid=0 | w=20
- chlorphéniramine ---
r_associated #0: 10 -->
en:naldecon
n1=chlorphéniramine | n2=en:naldecon | rel=r_associated | relid=0 | w=10
- phényléphrine ---
r_associated #0: 10 -->
en:naldecon
n1=phényléphrine | n2=en:naldecon | rel=r_associated | relid=0 | w=10
|